|

intravenous (IV) infusion Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • MediLink Therapeutics (Suzhou) Co., Ltd.1

Indications

  • Advanced Solid Tumors1
  • Cancer1

Denver, Colorado1 trial

A Clinical Study of YL205 in Patients With Advanced Solid Tumors

Sarah Cannon Research Institute (SCRI)- Denver

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.